Dessì M - Search Results

1

Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.

Mercuro G, Cadeddu C, Piras A, Dessì M, Madeddu C, Deidda M, Serpe R, Massa E, Mantovani G. Mercuro G, et al. Among authors: dessi m. Oncologist. 2007 Sep;12(9):1124-33. doi: 10.1634/theoncologist.12-9-1124. Oncologist. 2007. PMID: 17914082 Free article. Clinical Trial.

2

Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy.

Gramignano G, Lusso MR, Madeddu C, Massa E, Serpe R, Deiana L, Lamonica G, Dessì M, Spiga C, Astara G, Macciò A, Mantovani G. Gramignano G, et al. Among authors: dessi m. Nutrition. 2006 Feb;22(2):136-45. doi: 10.1016/j.nut.2005.06.003. Nutrition. 2006. PMID: 16459226

3

Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.

Mantovani G, Macciò A, Madeddu C, Gramignano G, Serpe R, Massa E, Dessì M, Tanca FM, Sanna E, Deiana L, Panzone F, Contu P, Floris C. Mantovani G, et al. Among authors: dessi m. Nutrition. 2008 Apr;24(4):305-13. doi: 10.1016/j.nut.2007.12.010. Epub 2008 Feb 11. Nutrition. 2008. PMID: 18262758 Clinical Trial.

4

Palonosetron plus dexamethasone effectively prevents acute and delayed chemotherapy-induced nausea and vomiting following highly or moderately emetogenic chemotherapy in pre-treated patients who have failed to respond to a previous antiemetic treatment: comparison between elderly and non-elderly patient response.

Massa E, Astara G, Madeddu C, Dessì M, Loi C, Lepori S, Mantovani G. Massa E, et al. Among authors: dessi m. Crit Rev Oncol Hematol. 2009 Apr;70(1):83-91. doi: 10.1016/j.critrevonc.2008.07.002. Epub 2008 Aug 23. Crit Rev Oncol Hematol. 2009. PMID: 18723369 Clinical Trial.

5

Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers.

Mantovani G, Madeddu C, Cadeddu C, Dessì M, Piras A, Massa E, Serpe R, Antoni G, Mercuro G. Mantovani G, et al. Among authors: dessi m. Oncologist. 2008 Dec;13(12):1296-305. doi: 10.1634/theoncologist.2008-0151. Epub 2008 Dec 5. Oncologist. 2008. PMID: 19060235 Free article.

6

Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia.

Mantovani G, Macciò A, Madeddu C, Serpe R, Antoni G, Massa E, Dessì M, Panzone F. Mantovani G, et al. Among authors: dessi m. J Mol Med (Berl). 2010 Jan;88(1):85-92. doi: 10.1007/s00109-009-0547-z. Epub 2009 Oct 3. J Mol Med (Berl). 2010. PMID: 19802504 Clinical Trial.

7

Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.

Mantovani G, Macciò A, Madeddu C, Serpe R, Massa E, Dessì M, Panzone F, Contu P. Mantovani G, et al. Among authors: dessi m. Oncologist. 2010;15(2):200-11. doi: 10.1634/theoncologist.2009-0153. Epub 2010 Feb 15. Oncologist. 2010. PMID: 20156909 Free PMC article. Clinical Trial.

8

Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment.

Cadeddu C, Piras A, Mantovani G, Deidda M, Dessì M, Madeddu C, Massa E, Mercuro G. Cadeddu C, et al. Among authors: dessi m. Am Heart J. 2010 Sep;160(3):487.e1-7. doi: 10.1016/j.ahj.2010.05.037. Am Heart J. 2010. PMID: 20826257 Clinical Trial.

9

Phase II study of vinorelbine/cetuximab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck progressing after at least two chemotherapy regimens.

Massa E, Dessì M, Gaspardini G, Saba F, Cherchi V, Mantovani G. Massa E, et al. Among authors: dessi m. Oral Oncol. 2010 Nov;46(11):818-21. doi: 10.1016/j.oraloncology.2010.08.013. Oral Oncol. 2010. PMID: 20920877 Clinical Trial.

10

Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome.

Madeddu C, Dessì M, Panzone F, Serpe R, Antoni G, Cau MC, Montaldo L, Mela Q, Mura M, Astara G, Tanca FM, Macciò A, Mantovani G. Madeddu C, et al. Among authors: dessi m. Clin Nutr. 2012 Apr;31(2):176-82. doi: 10.1016/j.clnu.2011.10.005. Epub 2011 Nov 1. Clin Nutr. 2012. PMID: 22047681 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters